Thomas A. Satterfield, Jr. 13D and 13G filings for Lantern Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-23 1:47 pm Purchase | 2026-06-30 | 13G | LANTERN PHARMA INC LTRN | Thomas A. Satterfield, Jr. | 975,000 7.600% | 405,000 (+71.05%) | Filing |
| 2026-04-03 10:53 am Purchase | 2026-03-30 | 13G | LANTERN PHARMA INC LTRN | Thomas A. Satterfield, Jr. | 570,000 5.100% | 570,000 (New Position) | Filing |